About Epstein-Barr Virus (EBV) Glycoprotein H (gH) Recombinant Protein

Epstein-Barr virus (EBV) is an enveloped double-stranded DNA virus belonging to the genus Lymphocryptovirus in the family Herpesviridae. Glycoprotein H (gH) is an essential envelope glycoprotein that forms a heterodimer with glycoprotein L (gL) to create the core viral fusion complex. Together with glycoprotein B (gB), the gH/gL complex mediates membrane fusion and viral entry into both B lymphocytes and epithelial cells. During B-cell infection, gH/gL associates with gp42, which binds HLA class II molecules to trigger membrane fusion. Because of its central role in viral entry, gH is a major target of neutralizing antibodies and an important antigen for vaccine development and antiviral research.

eEnzyme's EBV Glycoprotein H (gH) Recombinant Protein is produced for research use and is suitable for antibody screening, receptor-binding studies, ELISA development, Western blotting, epitope mapping, structural characterization, and EBV vaccine research. This recombinant protein provides a valuable reagent for investigating EBV-host interactions, membrane fusion mechanisms, immune responses, and antiviral therapeutic development.

Applications

Biological Significance of EBV Glycoprotein H

EBV gH is an essential component of the viral fusion machinery that enables infection of both B cells and epithelial cells through its interaction with gL, gB, and, in B cells, gp42. Because gH contains multiple conserved neutralizing epitopes and is indispensable for viral entry, it has become an important target for studies of EBV pathogenesis, vaccine design, and therapeutic antibody discovery. The EBV Glycoprotein H Recombinant Protein provides a valuable research tool for investigating herpesvirus entry mechanisms, immune responses, and the development of next-generation vaccines and antiviral therapeutics.